FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
9 letters match. Newest first.
-
BiologicsPlatinum Biologics LLC
FDA says Platinum Biologics sells unapproved umbilical cord and exosome biologics without required licenses or approvals.
High risk -
BiologicsChara Biologics, Inc.
FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.
High risk -
BiologicsEvolutionary Biologics Inc.
FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.
High risk -
BiologicsNeobiosis, LLC
FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.
High risk -
BiologicsKimera Labs, Inc.
FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.
High risk -
BiologicsAbbott Laboratories
FDA warns Abbott that Similac Probiotic Tri-Blend for preterm infants is an unapproved drug and adulterated supplement.
High risk -
BiologicsInvitrx Therapeutics, Inc.
Invitrx Therapeutics made unapproved umbilical cord and exosome products and had serious manufacturing deviations.
High risk -
BiologicsBioLab Sciences, Inc.
FDA warned BioLab Sciences that its injected amniotic fluid and skin products were unapproved biologics with serious manufacturing violations.
High risk -
BiologicsUtah Cord Bank LLC dba Utah Cell Bank
Utah Cell Bank made unapproved injectable stem cell products and fell short on sterility and manufacturing controls, FDA found.
High risk